Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Assets (2022 - 2025)

Historic Assets for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $53.2 million.

  • Lucid Diagnostics' Assets rose 13541.02% to $53.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.2 million, marking a year-over-year increase of 13541.02%. This contributed to the annual value of $30.7 million for FY2024, which is 1263.29% up from last year.
  • Per Lucid Diagnostics' latest filing, its Assets stood at $53.2 million for Q3 2025, which was up 13541.02% from $38.7 million recorded in Q2 2025.
  • In the past 5 years, Lucid Diagnostics' Assets ranged from a high of $62.1 million in Q1 2022 and a low of $22.6 million during Q3 2024
  • Over the past 4 years, Lucid Diagnostics' median Assets value was $34.1 million (recorded in 2024), while the average stood at $38.3 million.
  • As far as peak fluctuations go, Lucid Diagnostics' Assets plummeted by 3476.23% in 2024, and later skyrocketed by 13541.02% in 2025.
  • Quarter analysis of 4 years shows Lucid Diagnostics' Assets stood at $32.5 million in 2022, then decreased by 16.12% to $27.3 million in 2023, then increased by 12.63% to $30.7 million in 2024, then surged by 73.2% to $53.2 million in 2025.
  • Its last three reported values are $53.2 million in Q3 2025, $38.7 million for Q2 2025, and $32.8 million during Q1 2025.